A Simple Clinical Tool for Increasing Enrollment on a Kidney Transplant Waiting List for Patients Aged Over 70 and Initiating Dialysis
NCT ID: NCT02746146
Last Updated: 2021-03-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
46 participants
INTERVENTIONAL
2017-04-05
2020-03-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This prospective assessment is carried out as part of a historico-prospective before-after study in parallel with a survey of changes in national practices over the same time period via a here-elsewhere type study.
Historical data (i.e the. "before" period) will include incident dialysis cases during the calendar years 2013, 2014 and 2015 before the start of the prospective phase (i.e. "after" period, which is represented by the current declaration); since a preliminary study demonstrated that the data are comparable from 2011 to 2013, we will use the average of data thus obtained. Historical data will be retrieved from the REIN (The French Renal Epidemiology and Information Network) registry data and will be validated by investigators at each center.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Geriatric Assessment for Older Kidney Transplantation Candidates
NCT05395247
Development and Validation of a Multidimensional Score to Predict Long-term Kidney Transplant Outcomes
NCT03474003
Prediction of Chronic Allograft Nephropathy
NCT01380847
Evaluation of a New Regional Organization to Promote Access to Renal Transplantation
NCT03234075
Endovascular Preparation for Kidney Tranplantation
NCT06677437
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A. To show that the systematic use of the score at the initiation of dialysis can shorten the registration delay on a kidney transplant waiting list; to evaluate the time between initiation of dialysis and registration on a national waiting list for kidney transplants, while assessing the duration of the pre-transplant assessment.
B. To identify barriers to registration on the kidney transplant waiting list as well as the related time delay in this population (medical and non-medical factors), the rates and causes of patient refusal for registration and the possible evolution this refusal over time.
C. To evaluate the economic impact of the introduction of the renal transplant clinical prognostic score.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Chronic dialysis patients
The study population consists of patients over 70 (≥) and under 85 years (\<) of age with stage 5 chronic renal disease and initiating a first session of chronic dialysis in the Languedoc-Roussillon and Midi-Pyrénées regions. Eligible patients must have a 3 year prognostic mortality score less than (\<) 7 points (Dusseux et al. 2015).
Intervention: Systematic use of a prognostic score
Systematic use of a prognostic score
The prognostic score is given in Dusseux et al 2015. It will be used as soon as possible after the initiation of dialysis.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Systematic use of a prognostic score
The prognostic score is given in Dusseux et al 2015. It will be used as soon as possible after the initiation of dialysis.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The patient must be insured or beneficiary of a health insurance plan
* The patient is available for 12 months of follow-up
* Patient initiating chronic dialysis (incident cases)
* Patients with a 3 year prognostic mortality score less than (\<) 10 points (Dusseux et al. 2015)
Exclusion Criteria
* The patient is in an exclusion period determined by a previous study
* The patient is under judicial protection, under tutorship or curatorship
* The patient refuses to sign the consent
* It is impossible to correctly inform the patient
* Patient on preemptive kidney transplant waiting list (before the initiation of a chronic dialysis program)
70 Years
84 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nīmes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Olivier Moranne, MD, PhD
Role: STUDY_DIRECTOR
Centre Hospitalier Universitaire de Nîmes
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinique Claude Bernard
Albi, , France
AIDER - Unité de Dialyse d'Alès
Alès, , France
CH d'Auch
Auch, , France
Centre d'Hemodialyse Languedoc Méditérranéen
Béziers, , France
Medipole Grand Sud St Roch
Cabestany, , France
CH de Cahors
Cahors, , France
NephroCare
Castelnau-le-Lez, , France
CH de Carcassonne
Cité de Carcassonne, , France
AAIR Midi-Pyrénées
Colomiers, , France
Centre Hospitalier Intercommunal du Val d'Ariège
Foix, , France
Clinique du Pont de Chaume
Montauban, , France
AIDER de Montpellier
Montpellier, , France
CHRU de Montpellier - Hôpital Lapeyronie
Montpellier, , France
Clinique de l'Occitanie
Muret, , France
Polyclinique Le Languedoc
Narbonne, , France
AIDER - Unité de Dialyse de Nîmes
Nîmes, , France
CHRU de Nîmes - Hôpital Universitaire Carémeau
Nîmes, , France
Gardialyse
Nîmes, , France
CH de Perpignan - Hôpital Saint Jean
Perpignan, , France
Centre Hospitalier Jacques Puel
Rodez, , France
CH de Bigorre
Tarbes, , France
CHRU de Toulouse - Hôpital de Rangueil
Toulouse, , France
CHRU de Toulouse - Hôpital Larrey
Toulouse, , France
CHRU de Toulouse - Hôptal Casselardit
Toulouse, , France
Clinique Néphrologique Saint-Exupéry
Toulouse, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Dusseux E, Albano L, Fafin C, Hourmant M, Guerin O, Couchoud C, Moranne O. A simple clinical tool to inform the decision-making process to refer elderly incident dialysis patients for kidney transplant evaluation. Kidney Int. 2015 Jul;88(1):121-9. doi: 10.1038/ki.2015.25. Epub 2015 Feb 11.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016-A00464-47
Identifier Type: OTHER
Identifier Source: secondary_id
PHRC-I/2015/OM-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.